J.P. Morgan analyst Lisa Gill maintained a Buy rating on CVS Health (CVS – Research Report) yesterday and set a price target of $80.00. The company’s shares closed yesterday at $54.03. Gill covers the ...

TD Cowen analyst Charles Rhyee maintained a Buy rating on CVS Health (CVS – Research Report) today and set a price target of $85.00. The ...

For CVS, this year has been defined by an unsuccessful fight against elevated medical costs. The third quarter was no different. “We have been more acutely impacted than others in the industry ...

We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...

CVS reported mixed third-quarter results shadowed by heightened medical costs on Wednesday, in the massive healthcare enterprise’s first earnings report with new CEO David Joyner at the helm ...

Our expert, award-winning staff selects the products we cover and rigorously researches and tests our top picks. If you buy through our links, we may get a commission. Reviews ethics statement ...

Longtime CVS Health executive David Joyner has replaced Karen Lynch as CEO, as the company struggles to drive higher profits and stock performance, CVS announced Friday. The move, effective ...

America’s largest drug store chain named a new chief executive officer on Friday, with longtime CVS Health executive David Joyner replacing Karen Lynch. CVS also withdrew its 2024 profit ...

CVS Health (NYSE: CVS, $67.46, Market Capitalization: $84.86 billion), a leading health solutions company in the US, is considering a potential break-up to separate its retail and insurance units.

CVS gives third-quarter outlook below Street estimates Activist Glenview Capital says CVS board needs 'evolution' CVS plans to remain as one company under Joyner, sources say Oct 18 (Reuters ...

CVS Health CEO Karen Lynch has stepped down, with company shares sinking 19% this year and the health-care giant struggling on several fronts. Company shares tumbled again Friday after CVS Health ...